Table 3.
Evaluation of the clinical efficacy of the PFO closure procedure in adolescents with migraine.
| M0 | M6 | M12 | |
|---|---|---|---|
| VAS | 7.63 ± 0.87 | 2.56 ± 2.85 | 2.12 ± 2.65 |
| HIT-6 | 66.94 ± 4.80 | 46.28 ± 12.25 | 43.99 ± 10.85 |
| PedMIDAS | 49.73 ± 7.52 | 12.40 ± 15.63 | 8.60 ± 15.38 |
| Frequency | 7.35 ± 2.60 | 2.23 ± 2.90 | 1.60 ± 2.72 |
| Duration | 12.34 ± 3.44 | 4.05 ± 4.88 | 3.27 ± 4.73 |
| Migraine burden | 91.87 ± 44.62 | 20.73 ± 34.13 | 15.48 ± 34.42 |
VAS, Visual Analogue Scale; HIT-6, Headache Impact Test; PedMIDSA, Pediatric Migraine Disability Assessment; M0, Baseline; M6, at 6 months postoperatively; M12, at 12 months postoperatively; PFO, patent foramen ovale.